Alterity Therapeutics (ATHE) Receivables (2014 - 2025)
Alterity Therapeutics (ATHE) posted quarterly Receivables of $2.5 million for Q2 2025, down 5.32% year-over-year from $2.7 million in Q2 2024, and down 5.32% quarter-over-quarter from $2.7 million in Q2 2024.
Alterity Therapeutics (ATHE) Receivables (2014 - 2025) Analysis & Trends
Alterity Therapeutics' Receivables history runs 10 years deep, the most recent figure standing at $2.5 million for Q2 2025.
- In Q2 2025, Receivables fell 5.32% year-over-year to $2.5 million; the TTM figure through Jun 2025 stood at $2.5 million (down 5.32% YoY), while the FY2025 annual figure was $2.5 million, down 5.32% from the prior year.
- Receivables for Q2 2025 stood at $2.5 million, down from $2.7 million in the prior quarter.
- The five-year high for Receivables was $6.1 million in Q4 2021, with the low at $2.5 million in Q2 2025.
- The 5-year median for Receivables is $3.4 million (2021), against an average of $4.0 million.
- The sharpest annual moves came in 2021 and 2024: Receivables jumped 8293.97% in 2021, then sank 54.52% in 2024.
- Alterity Therapeutics' Receivables stood at $6.1 million in 2021, then slumped by 44.65% to $3.4 million in 2022, then surged by 73.05% to $5.9 million in 2023, then tumbled by 54.52% to $2.7 million in 2024, then retreated by 5.32% to $2.5 million in 2025.
- Business Quant data shows ATHE's Receivables at $2.5 million in Q2 2025, $2.7 million in Q2 2024, and $5.9 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Alterity Therapeutics | 49.04 Mn | 16.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.52 Mn |
| Jun 30, 2024 | 2.66 Mn |
| Jun 30, 2023 | 5.86 Mn |
| Jun 30, 2022 | 3.38 Mn |
| Dec 31, 2021 | 6.12 Mn |
| Jun 30, 2021 | 3.37 Mn |
| Dec 31, 2020 | 1.45 Mn |
| Jun 30, 2020 | 40,191.05 |
| Jun 30, 2019 | 3.38 Mn |
| Jun 30, 2018 | 2.39 Mn |
| Jun 30, 2017 | 2.28 Mn |
| Dec 31, 2014 | 96,526.23 |